跳至主要内容
临床试验/DRKS00016462
DRKS00016462已完成未知

Growth and Tolerance of Healthy Term Infants Fed Infant Formula With 100% Whey Protein Hydrolysate or Intact Milk Proteins (Penguin Project)

Fonterra Co-operative Group Limited0 个研究点目标入组 251 人开始时间: 2019年1月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
251

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
one 至 28 Days(—)
性别
All

入选标准

  • singleton full term birth
  • birth weight 2500 to 4500g
  • Apgar (any) = 7
  • Age 0 to 28 days
  • exclusively breast-fed (breastfed reference arm) or formula-fed (formula-fed arms) at enrolment and for at least 90 days thereafter
  • informed consent from parents/legal guardians

排除标准

  • adverse maternal, foetal or Infant medical history with effects on growth or feeding tolerance
  • maternal gestational diabetes
  • allergy to cow´s milk proteins or increased risk of allergy
  • rehospitalisation within 5 days of birth
  • use of medication that affects gastrointestinal tolerance (incl. antibiotic therapy)
  • participation in another clinical trial
  • intention to use mixed feeding
  • investigators uncertainty about the willingness or ability of the parents to comply with the protocol requirements

研究者

相似试验